de Hora, M.R.; Heather, N.L.; Patel, T.; Bresnahan, L.G.; Webster, D.; Hofman, P.L.
Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand. Int. J. Neonatal Screen. 2020, 6, 6.
https://doi.org/10.3390/ijns6010006
AMA Style
de Hora MR, Heather NL, Patel T, Bresnahan LG, Webster D, Hofman PL.
Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand. International Journal of Neonatal Screening. 2020; 6(1):6.
https://doi.org/10.3390/ijns6010006
Chicago/Turabian Style
de Hora, Mark R., Natasha L. Heather, Tejal Patel, Lauren G. Bresnahan, Dianne Webster, and Paul L. Hofman.
2020. "Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand" International Journal of Neonatal Screening 6, no. 1: 6.
https://doi.org/10.3390/ijns6010006
APA Style
de Hora, M. R., Heather, N. L., Patel, T., Bresnahan, L. G., Webster, D., & Hofman, P. L.
(2020). Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand. International Journal of Neonatal Screening, 6(1), 6.
https://doi.org/10.3390/ijns6010006